OBJECTIVE: Fetal exposure to maternal anti-SSA/Ro antibodies is necessary but not sufficient for the development of autoimmune congenital heart block (CHB), suggesting that other factors, such as fetal genetic predisposition, are important. Given the previously described association between major histocompatibility complex alleles and CHB risk, we undertook the present study to test the hypothesis that a variant form of HLA-C Asn80Lys, which binds with high affinity to an inhibitory killer cell immunoglobulin-like receptor (KIR) and thus renders natural killer (NK) cells incapable of restricting inflammation, contributes to the development of CHB. METHODS: Members of 192 pedigrees in the US and Europe (194 cases of CHB, 91 unaffected siblings, 152 fathers, 167 mothers) and 1,073 out-of-study controls were genotyped on the Immunochip single-nucleotide polymorphism microarray. Imputation was used to identify associations at HLA-C Asn80Lys (Asn, C1; Lys, C2) and KIR. Tests for association were performed using logistic regression. McNemar's test and the pedigree disequilibrium test (PDT) were used for matched analyses between affected and unaffected children. RESULTS: Compared with out-of-study controls of the same sex, the C2 allele was less frequent in the mothers (odds ratio [OR] 0.63, P = 0.0014) and more frequent in the fathers (OR 1.40, P = 0.0123), yielding a significant sex-by-C2 interaction (P = 0.0002). The C2 allele was more frequent in affected siblings than in unaffected siblings (OR 3.67, P = 0.0025), which was consistent with the PDT results (P = 0.016); these results were observed in both sexes and across the US and European cohorts. There was no difference in the frequency of the inhibitory KIR genotype (KIR AA) between affected and unaffected children (P = 0.55). CONCLUSION: These data establish C2 as a novel genetic risk factor associated with CHB. This observation supports a model in which fetuses with C2 ligand expression and maternal anti-SSA/Ro positivity may have impaired NK cell surveillance, resulting in unchecked cardiac inflammation and scarring.
OBJECTIVE: Fetal exposure to maternal anti-SSA/Ro antibodies is necessary but not sufficient for the development of autoimmune congenital heart block (CHB), suggesting that other factors, such as fetal genetic predisposition, are important. Given the previously described association between major histocompatibility complex alleles and CHB risk, we undertook the present study to test the hypothesis that a variant form of HLA-CAsn80Lys, which binds with high affinity to an inhibitory killer cell immunoglobulin-like receptor (KIR) and thus renders natural killer (NK) cells incapable of restricting inflammation, contributes to the development of CHB. METHODS: Members of 192 pedigrees in the US and Europe (194 cases of CHB, 91 unaffected siblings, 152 fathers, 167 mothers) and 1,073 out-of-study controls were genotyped on the Immunochip single-nucleotide polymorphism microarray. Imputation was used to identify associations at HLA-CAsn80Lys (Asn, C1; Lys, C2) and KIR. Tests for association were performed using logistic regression. McNemar's test and the pedigree disequilibrium test (PDT) were used for matched analyses between affected and unaffected children. RESULTS: Compared with out-of-study controls of the same sex, the C2 allele was less frequent in the mothers (odds ratio [OR] 0.63, P = 0.0014) and more frequent in the fathers (OR 1.40, P = 0.0123), yielding a significant sex-by-C2 interaction (P = 0.0002). The C2 allele was more frequent in affected siblings than in unaffected siblings (OR 3.67, P = 0.0025), which was consistent with the PDT results (P = 0.016); these results were observed in both sexes and across the US and European cohorts. There was no difference in the frequency of the inhibitory KIR genotype (KIR AA) between affected and unaffected children (P = 0.55). CONCLUSION: These data establish C2 as a novel genetic risk factor associated with CHB. This observation supports a model in which fetuses with C2 ligand expression and maternal anti-SSA/Ro positivity may have impaired NK cell surveillance, resulting in unchecked cardiac inflammation and scarring.
Authors: Francesca Bellora; Roberta Castriconi; Alessandra Dondero; Giorgio Reggiardo; Lorenzo Moretta; Alberto Mantovani; Alessandro Moretta; Cristina Bottino Journal: Proc Natl Acad Sci U S A Date: 2010-11-30 Impact factor: 11.205
Authors: Carolina Llanos; Deborah M Friedman; Amit Saxena; Peter M Izmirly; Chung-E Tseng; Renata Dische; Rosanna G Abellar; Marc Halushka; Robert M Clancy; Jill P Buyon Journal: Rheumatology (Oxford) Date: 2012-02-03 Impact factor: 7.580
Authors: S Meisgen; T Östberg; S Salomonsson; B Ding; H Eliasson; A Mälarstig; L Alfredsson; L Klareskog; A Hamsten; T Olsson; T Axelsson; F Gadler; A Jonzon; S-E Sonesson; I Kockum; M Wahren-Herlenius Journal: J Intern Med Date: 2014-01-20 Impact factor: 8.989
Authors: Robert R Graham; Ward Ortmann; Peter Rodine; Karl Espe; Carl Langefeld; Ethan Lange; Adrienne Williams; Stephanie Beck; Chieko Kyogoku; Kathy Moser; Patrick Gaffney; Peter K Gregersen; Lindsey A Criswell; John B Harley; Timothy W Behrens Journal: Eur J Hum Genet Date: 2007-04-04 Impact factor: 4.246
Authors: Robert M Clancy; Miranda C Marion; Kenneth M Kaufman; Paula S Ramos; Adam Adler; John B Harley; Carl D Langefeld; Jill P Buyon Journal: Arthritis Rheum Date: 2010-11
Authors: Florian Babor; Angela R Manser; Johannes C Fischer; Nadine Scherenschlich; Jürgen Enczmann; Olympe Chazara; Ashley Moffett; Arndt Borkhardt; Roland Meisel; Markus Uhrberg Journal: Blood Date: 2014-08-27 Impact factor: 22.113
Authors: Carl D Langefeld; Hannah C Ainsworth; Deborah S Cunninghame Graham; Jennifer A Kelly; Mary E Comeau; Miranda C Marion; Timothy D Howard; Paula S Ramos; Jennifer A Croker; David L Morris; Johanna K Sandling; Jonas Carlsson Almlöf; Eduardo M Acevedo-Vásquez; Graciela S Alarcón; Alejandra M Babini; Vicente Baca; Anders A Bengtsson; Guillermo A Berbotto; Marc Bijl; Elizabeth E Brown; Hermine I Brunner; Mario H Cardiel; Luis Catoggio; Ricard Cervera; Jorge M Cucho-Venegas; Solbritt Rantapää Dahlqvist; Sandra D'Alfonso; Berta Martins Da Silva; Iñigo de la Rúa Figueroa; Andrea Doria; Jeffrey C Edberg; Emőke Endreffy; Jorge A Esquivel-Valerio; Paul R Fortin; Barry I Freedman; Johan Frostegård; Mercedes A García; Ignacio García de la Torre; Gary S Gilkeson; Dafna D Gladman; Iva Gunnarsson; Joel M Guthridge; Jennifer L Huggins; Judith A James; Cees G M Kallenberg; Diane L Kamen; David R Karp; Kenneth M Kaufman; Leah C Kottyan; László Kovács; Helle Laustrup; Bernard R Lauwerys; Quan-Zhen Li; Marco A Maradiaga-Ceceña; Javier Martín; Joseph M McCune; David R McWilliams; Joan T Merrill; Pedro Miranda; José F Moctezuma; Swapan K Nath; Timothy B Niewold; Lorena Orozco; Norberto Ortego-Centeno; Michelle Petri; Christian A Pineau; Bernardo A Pons-Estel; Janet Pope; Prithvi Raj; Rosalind Ramsey-Goldman; John D Reveille; Laurie P Russell; José M Sabio; Carlos A Aguilar-Salinas; Hugo R Scherbarth; Raffaella Scorza; Michael F Seldin; Christopher Sjöwall; Elisabet Svenungsson; Susan D Thompson; Sergio M A Toloza; Lennart Truedsson; Teresa Tusié-Luna; Carlos Vasconcelos; Luis M Vilá; Daniel J Wallace; Michael H Weisman; Joan E Wither; Tushar Bhangale; Jorge R Oksenberg; John D Rioux; Peter K Gregersen; Ann-Christine Syvänen; Lars Rönnblom; Lindsey A Criswell; Chaim O Jacob; Kathy L Sivils; Betty P Tsao; Laura E Schanberg; Timothy W Behrens; Earl D Silverman; Marta E Alarcón-Riquelme; Robert P Kimberly; John B Harley; Edward K Wakeland; Robert R Graham; Patrick M Gaffney; Timothy J Vyse Journal: Nat Commun Date: 2017-07-17 Impact factor: 14.919
Authors: Sabrina Meisgen; Malin Hedlund; Aurelie Ambrosi; Lasse Folkersen; Vijole Ottosson; David Forsberg; Gudny Ella Thorlacius; Luca Biavati; Linn Strandberg; Johannes Mofors; Daniel Ramskold; Sabrina Ruhrmann; Lauro Meneghel; William Nyberg; Alexander Espinosa; Robert Murray Hamilton; Anders Franco-Cereceda; Anders Hamsten; Tomas Olsson; Lois Greene; Per Eriksson; Kristina Gemzell-Danielsson; Stina Salomonsson; Vijay K Kuchroo; Eric Herlenius; Ingrid Kockum; Sven-Erik Sonesson; Marie Wahren-Herlenius Journal: Ann Rheum Dis Date: 2022-04-25 Impact factor: 27.973